Linike Financial Statements From 2010 to 2025
| LNMG Stock | USD 0.02 0 22.50% |
Check Linike Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Linike Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Linike financial statements analysis is a perfect complement when working with Linike Medical Valuation or Volatility modules.
Linike |
Linike Medical Group Company Current Valuation Analysis
Linike Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Linike Medical Current Valuation | 5.21 M |
Most of Linike Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Linike Medical Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Linike Medical Group has a Current Valuation of 5.21 M. This is 99.98% lower than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The current valuation for all United States stocks is 99.97% higher than that of the company.
Linike Medical Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Linike Medical's current stock value. Our valuation model uses many indicators to compare Linike Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Linike Medical competition to find correlations between indicators driving Linike Medical's intrinsic value. More Info.Linike Medical Group is currently regarded as number one stock in return on asset category among its peers. It also is considered the number one company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Linike Medical's earnings, one of the primary drivers of an investment's value.About Linike Medical Financial Statements
Linike Medical stakeholders use historical fundamental indicators, such as Linike Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Linike Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Linike Medical's assets and liabilities are reflected in the revenues and expenses on Linike Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Linike Medical Group. Please read more on our technical analysis and fundamental analysis pages.
Linike Medical Group Ltd engages in the renewable energy business. The company was formerly known as Litian Group Inc. and changed its name to Linike Medical Group Ltd in August 2021. Linike Medical is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Linike Pink Sheet
Linike Medical financial ratios help investors to determine whether Linike Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Linike with respect to the benefits of owning Linike Medical security.